Medicare Part D Utilization, Spending, and Formulary Coverage of Brand-name Disease Modifying Therapies with Generics Available for Multiple Sclerosis

Cranial Neuropathies as Adverse Events from Immune Checkpoint Inhibitors

An Updated Evaluation of Multiple Sclerosis Outcomes After Immune Checkpoint Inhibitors from the FAERS Database